Bigfoot Biomedical is a company known for optimizing insulin delivery. And recently, the company announced it raised $45 million in an initial tranche of a Series C equity financing.
Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for serious autoimmune diseases, which recently raised $25 million.
dot.LA, an upcoming news and events company dedicated to covering L.A.’s startup and tech ecosystem, announced it raised $4 million in a seed round of funding.
BioSkryb, a developer of genomic amplification technologies that deliver higher coverage and fidelity for gene sequencing, announced it raised $11.5 million in funding.
Pulse 2.0 NewsletterDaily business and finance intelligence.
Subscribe to the Pulse 2.0 Newsletter
Stay informed with the day's intelligence on business, finance, capital markets, deal flow, law, tech, and AI delivered to your inbox each evening at 6pm ET.